1 | Journal Copy | 10 Oct 1986 |
10 | TM-12 | 26 Sep 2016 |
11 | TM-50 | 14 Feb 2017 |
2 | Additional Representation Sheet | 30 Oct 1996 |
2 | Certificate | 30 Oct 1996 |
3 | Certificate | 30 Oct 1996 |
3 | Examination Report | 30 Oct 1996 |
4 | Note Sheet | 30 Oct 1996 |
4 | Other Documents | 30 Oct 1996 |
5 | Examination Report | 30 Oct 1996 |
5 | Other Documents | 30 Oct 1996 |
6 | Additional Representation Sheet | 30 Oct 1996 |
6 | TM-1 | 30 Oct 1996 |
7 | Note Sheet | 30 Oct 1996 |
7 | TM-1 | 30 Oct 1996 |
8 | TM-1 | 30 Oct 1996 |
9 | Returned Notices / Correspondences | 10 Aug 2016 |
1 | O3 NOTICE | 3769198 | 1866632 | 19 Jul 2016 |
2 | RENEWAL INTIMATION LETTER | 4086608 | 12 Oct 2016 |
The application for Doliprane was made on 31 October 1996.
The trademark applicant for Doliprane is ABBOTT HEALTHCARE.
Doliprane is applied in class(es) 5.
Application for Doliprane is on Registered stage.
Application Id allotted to Doliprane is 720137.
Trademark agent or attorney for the application is Zeusip.
Doliprane filed with the Intellectual property office as a WORD.